Heidi W. Trask

583 total citations
21 papers, 464 citations indexed

About

Heidi W. Trask is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Heidi W. Trask has authored 21 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 3 papers in Rheumatology. Recurrent topics in Heidi W. Trask's work include Porphyrin Metabolism and Disorders (5 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Heidi W. Trask is often cited by papers focused on Porphyrin Metabolism and Disorders (5 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). Heidi W. Trask collaborates with scholars based in United States and United Kingdom. Heidi W. Trask's co-authors include Craig R. Tomlinson, Carol S. Ringelberg, Joanna S. Kerley-Hamilton, Murray Korc, Jiang Gui, Barjor Gimi, Benjamin Moyer, Krishnamurthy V. Nemani, C. Ridley and Éric Dufour and has published in prestigious journals such as PLoS ONE, Hepatology and Biochemical and Biophysical Research Communications.

In The Last Decade

Heidi W. Trask

21 papers receiving 459 citations

Peers

Heidi W. Trask
Wojciech G. Garbacz United States
Larry N Agbor United States
Yijiao Xu China
Laurel A. Coons United States
Peter Dornbos United States
Heidi W. Trask
Citations per year, relative to Heidi W. Trask Heidi W. Trask (= 1×) peers Aline Chevallier

Countries citing papers authored by Heidi W. Trask

Since Specialization
Citations

This map shows the geographic impact of Heidi W. Trask's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heidi W. Trask with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heidi W. Trask more than expected).

Fields of papers citing papers by Heidi W. Trask

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heidi W. Trask. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heidi W. Trask. The network helps show where Heidi W. Trask may publish in the future.

Co-authorship network of co-authors of Heidi W. Trask

This figure shows the co-authorship network connecting the top 25 collaborators of Heidi W. Trask. A scholar is included among the top collaborators of Heidi W. Trask based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heidi W. Trask. Heidi W. Trask is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilkins, Owen M., Chenyang Li, Fred Kolling, et al.. (2023). Characterizing control of memory CD8 T cell differentiation by BTB-ZF transcription factor Zbtb20. Life Science Alliance. 6(9). e202201683–e202201683. 4 indexed citations
2.
Chamberlin, Mary D., Kevin Shee, Jonathan D. Marotti, et al.. (2020). Plasma DNA as a “liquid biopsy” incompletely complements tumor biopsy for identification of mutations in a case series of four patients with oligometastatic breast cancer. Breast Cancer Research and Treatment. 182(3). 665–677. 1 indexed citations
3.
Moyer, Benjamin, Joanna S. Kerley-Hamilton, Krishnamurthy V. Nemani, et al.. (2017). Obesity and fatty liver are prevented by inhibition of the aryl hydrocarbon receptor in both female and male mice. Nutrition Research. 44. 38–50. 45 indexed citations
4.
Moyer, Benjamin, Joanna S. Kerley-Hamilton, Haley F. Hazlett, et al.. (2016). Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1. Toxicology and Applied Pharmacology. 300. 13–24. 103 indexed citations
5.
Kerley-Hamilton, Joanna S., Heidi W. Trask, C. Ridley, et al.. (2012). Inherent and Benzo[a]pyrene-Induced Differential Aryl Hydrocarbon Receptor Signaling Greatly Affects Life Span, Atherosclerosis, Cardiac Gene Expression, and Body and Heart Growth in Mice. Toxicological Sciences. 126(2). 391–404. 59 indexed citations
6.
Kerley-Hamilton, Joanna S., Heidi W. Trask, C. Ridley, et al.. (2012). Obesity Is Mediated by Differential Aryl Hydrocarbon Receptor Signaling in Mice Fed a Western Diet. Environmental Health Perspectives. 120(9). 1252–1259. 78 indexed citations
7.
Fellows, Abigail M., Judith M. Jacobs, Heidi W. Trask, et al.. (2012). Arsenic decreases RXRα-dependent transcription of CYP3A and suppresses immune regulators in hepatocytes. International Immunopharmacology. 12(4). 651–656. 10 indexed citations
8.
Trask, Heidi W., Carol S. Ringelberg, C. Ridley, et al.. (2011). SMAD4‐dependent polysome RNA recruitment in human pancreatic cancer cells. Molecular Carcinogenesis. 51(10). 771–782. 2 indexed citations
9.
Trask, Heidi W., C. Ridley, Murray Korc, et al.. (2011). Differential regulation of polysome mRNA levels in mouse Hepa-1C1C7 cells exposed to dioxin. Toxicology in Vitro. 25(7). 1457–1467. 9 indexed citations
10.
Nakamura, Kenta, Nobuyasu Maki, Heidi W. Trask, et al.. (2010). miRNAs in Newt Lens Regeneration: Specific Control of Proliferation and Evidence for miRNA Networking. PLoS ONE. 5(8). e12058–e12058. 35 indexed citations
11.
Trask, Heidi W., Richard Cowper‐Sal·lari, Maureen A. Sartor, et al.. (2009). Microarray analysis of cytoplasmic versus whole cell RNA reveals a considerable number of missed and false positive mRNAs. RNA. 15(10). 1917–1928. 27 indexed citations
12.
Jacobs, Judith M., et al.. (2006). Effect of proteasome inhibition on toxicity and CYP3A23 induction in cultured rat hepatocytes: Comparison with arsenite. Toxicology and Applied Pharmacology. 217(3). 245–251. 3 indexed citations
13.
Kostrubsky, Vsevolod E., Sheryl G. Wood, Ralph C. Nichols, et al.. (2005). ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES. Drug Metabolism and Disposition. 33(7). 993–1003. 28 indexed citations
14.
Jacobs, Judith M., Ralph C. Nichols, Heidi W. Trask, et al.. (2005). Mechanism of arsenite-mediated decreases in CYP3A23 in rat hepatocytes. Biochemical and Biophysical Research Communications. 333(4). 1211–1217. 5 indexed citations
15.
Trask, Heidi W., Nadia Gorman, Barney E. Dwyer, et al.. (2005). Effect of insulin and glucagon on accumulation of uroporphyrin and coproporphyrin from 5-aminolevulinate in hepatocyte cultures. Archives of Biochemistry and Biophysics. 439(1). 1–11. 1 indexed citations
16.
Jacobs, Judith M., Ralph C. Nichols, Heidi W. Trask, et al.. (2005). Arsenite decreases CYP3A23 induction in cultured rat hepatocytes by transcriptional and translational mechanisms. Toxicology and Applied Pharmacology. 209(2). 174–182. 12 indexed citations
17.
Gorman, Nadia, Heidi W. Trask, William J. Bement, et al.. (2004). Genetic factors influence ethanol-induced uroporphyria in Hfe (—/—) mice. Hepatology. 40(4). 942–950. 7 indexed citations
18.
Gorman, Nadia, Heidi W. Trask, William J. Bement, et al.. (2004). Genetic factors influence ethanol-induced uroporphyria inHfe(?/?) mice. Hepatology. 40(4). 942–950. 10 indexed citations
19.
Sinclair, Peter R., Nadia Gorman, Heidi W. Trask, et al.. (2003). Uroporphyria caused by ethanol in Hfe (−/−) mice as a model for porphyria cutanea tarda. Hepatology. 37(2). 351–358. 13 indexed citations
20.
Nichols, Ralph C., Sandra Cooper, Heidi W. Trask, et al.. (2003). Uroporphyrin accumulation in hepatoma cells expressing human or mouse CYP1A2: relation to the role of CYP1A2 in human porphyria cutanea tarda. Biochemical Pharmacology. 65(4). 545–550. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026